World Metastasis Summit 2019

World Metastasis Summit is organized by Front Line Genomics and will be held from Nov 20 - 21, 2019 at Hyatt Regency Boston, Boston, Massachusetts, United States of America.

Why Attend?
• Unlock New Therapeutic Avenues
• Shape Your Strategy Using Experts
• Improve Clinical Success
• Make New Connections

Description:
It’s estimated that 90% of dying cancer patients die from cancer metastasis. There is currently no cure. Less than 5% of cancer funds go towards tackling metastatic cancer. That’s a dire situation for cancer patients and their families, and it needs to change.

Unlike some other existing (and fantastic) research-oriented metastatic cancer events, this event is the first to move beyond basic research and focus on the development of effective therapies.

Given the urgency of this event, it is crucial that the right people are there. This event will bring together the entire oncology community - pharma, researchers, clinicians and advocates– to create meaningful change for patients. Our speakers include cancer research pioneers such as Bob Weinberg and Bob Kerbel as well as global leaders and decision-makers in translational oncology. This meeting will address a range of incredible new therapeutic opportunities in a friendly, welcoming environment conducive to deep learning and networking.

 Key Benefits of Attending:
• Explore some of the latest scientific insights into the complex metastatic cascade, and gain insight into the most promising therapeutic avenues for drug developers to explore in the near term. 
• Learn from the successes and failures in metastasis research, with the hope of fostering collaboration throughout the drug discovery pipeline.
• Realise how pharma can rise to the challenge and work with experts in pre-clinical modelling to prioritise pre-clinical testing for metastasis.
• Hear case studies from experts in immuno-oncology, to understand how we can overcome some of the biggest barriers in translation.
• Network among research pioneers and global leaders in translational oncology.

Key Topics Include:
• Translate metastasis research into the clinic.
• Implement metastatic models.
• Stop metastasis earlier.
• AI and metastasis.
• Biomarkers and metastasis.
• Dormancy.
• Immuno-oncology and metastasis.
• Cancer as a metabolic disease.
• Overcoming anti-metastatic bottlenecks.
• The microbiome and metastasis.
• Endpoints and clinical trials.
• Leverage data-driven approaches.